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SIUMMARY
The sequence variation in a 934 base-pair region of the gene encoding the
haemagglutinin-neuraminidase of five human parainfluenza virus type 3 (HPIV3)
isolates was determined together with that of a prototype UK strain. All of the
clinical isolates were from the Manchester area of the UK and were obtained in
1990, 1991 and 1993. The gene segment was amplified by the polymerase chain
reaction using HPIV'3-specific oligonucleotide primers. The nucleotide homology
of the strains was high, around 99% and specific differences in the UK sequences
when compared with that of the US prototype strain were identified. In addition,
a number of isolate-specific differences were seen. No correlation was detected
between the observed nucleotide mutations and the year of isolation, which
supports the hypothesis that HPIV'3 shows cocirculation of a heterogeneous
population of viruses rather than varying with time in a linear fashion. However,
the data suggested that geographically-defined genetic lineages of HPIV3 may
exist.
INTRODUCTION
Human parainfluenza virus 3 (HPIV3) infections are a major cause of
respiratory tract infections in young infants [1] and are second only to respiratory
syncvtial virus in incidence [2]. HPIV3 infection occurs world-wide and, in the
United Kingdom at least, follows an epidemic pattern with peak incidence
occurring in the summer months in weeks 21-32 [3]. Many sporadic cases of
infection are observed between the peak periods and these may account for the
earlier long-held view that HPIV3 was endemic [3]. Currently no effective vaccine
is available.
Several studies have been carried out on the relatedness and possible evolution
of the mammalian parainfluenza viruses, both by nucleotide sequence comparisons
and by using panels of monoclonal antibodies (MAb). A panel of MAb raised
against the haemagglutinin-neuraminidase (HN), fusion (F), nucleocapsid (N) and
matrix (M) proteins of PIV3 strains showed little relationship between human and
bovine viruses [4, 5]. and of these proteins the most antigenically divergent was
HN [6].
Previous investigations have concentrated on the antigenic [7] and nucleotide
diversity of clinical isolates of HPIV3 from diverse geographical locations over a
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wide time scale. van Wyke Coelingh, Winter and Murphy [8, 9] sequenced the HN
and F genes of six clinical isolates obtained from Texas and Washington USA and
Australia between 1973-83. These strains were found to be highly conserved in
both genes, with approximately 3% amino acid variability seen between isolates.
The antigenic analysis was carried out on a larger sample number, and variation
within the HN protein could sometimes be correlated with the geographic origin
of the strain, although this was not observed with the smaller number of strains
sequenced. The nucleotide diversity of the HPIV3 HN gene showed a similar
pattern to that of influenza C virus, with an overall low rate of non-cumulative
change and genetic heterogeneity rather than the progressive accumulation of
mutations observed in the influenza A virus attachment gene.
It has recently been shown with HPIVI that although cocirculation of strains
is commonly seen, geographical lineages may develop [10]. However, it is not
known whether such geographical lineages develop with HPIV3 infections.
Comparison of the sequence data for UK isolates with other known HPIV3
sequences may provide information on whether such a geographical lineage has
developed for HPIV3.
We report here an investigation of the sequence variability in the HN gene of
HPIV3 within isolates obtained from a restricted area over a short time period to
determine whether cocirculation of HPIV3 variants occurs or whether a
geographically restricted monotypic variant has developed. The isolates examined
were obtained over a period of three epidemics in one geographical area of the
United Kingdom (Manchester).
MATERIALS AND METHODS
Virus strains
Clinical isolates, identified by direct immunofluorescence of throat swab
material, were provided by Dr A. Turner of the Public Health Laboratory,
Manchester. The isolates were supplied either as an aliquot of original sample
material, or as tissue culture fluid from a first passage in cell culture (Table 1).
Strain MK9, provided by the Public Health Laboratory, Colindale, London was
used as a UK 'prototype' HPIV3 strain. Viruses were grown in BSC-1 monkey
green kidney cells passaged twice or three times to provide sufficient material for
analysis.
PCR amplification and cloning
Cytoplasmic RNA was extracted from infected cells as described previously[1 1].
This was used to direct synthesis of cDNA using an oligo(dT) oligonucleotide
primer and the cDNA was amplified by polymerase chain reaction (PCR) at 94 °C
for 45 s, 54 °C for 45 s and 74 °C for 2 min for 30 cycles [12]. The primers used were
HN2 and HN4 (C938ATCATCAGGCATAGAAG955 and A1872CTAATGAATAG1861
respectively). The nucleotide positions of the 5' and 3' residues are indicated.
Following analysis of all of the sequences for the HN genes of HPIV1, HPIV2 and
HPIV3 available on the GENEMBL database, the primers were designed to fall
within totally conserved regions of all HPIV3 isolates sequenced to date and
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Table 1. HPIV3 isolates
Year of Age of
Isolate isolation patient Sex
X790/02293 1990 1 month Female
V90/02499 1990 1 year Male
V91/01836 1991 4 months Female
V'91/02200 1991 4 months Female
X93/03469 1993 8 months Male
* Virus isolates used in this study.
amplified a fragment of 934 base pairs. In addition, the primers were also designed
to decrease the possibility of amplifying any misdiagnosed HPIVi or HPIV2
isolates by selecting areas of sequence variation between these viruses and HPIV3.
PCR fragments were isolated from agarose gels and inserted into bacteriophage
M13 DNA or the pCRmII cloning vector (InVitrogen BV) using standard
techniques [13] either directly or following digestion with the restriction
endonuclease Bgl II which recognized a single site within the amplified DNA.
These were then amplified in E. coli.
DNA sequencing
Nucleotide sequence analysis was carried out using the dideoxy chain
termination method [14]. The 35S-dATP radioactive label was supplied by
Amersham International plc. All other reagents were supplied in the SequenaseTM
kit version 2-0 (United States Biochemical Corp.). The protocol was carried out in
accordance with the manufacturers recommendations. All inserts were sequenced
at least twice.
RESULTS AND DISCUSSION
Sequences were compared with the prototype strain of HPIV3
P13/Wash/47885/57 [14]. As a consequence of the cloning and sequencing
strategies employed, the region between residues 938-1331 of strain V90/02293
and residues 1347-1362 of strains V91/02200 and V93/03469 could not be
determined unambiguously and have been omitted from subsequent analyses.
When the determined sequences were compared it was seen that no insertions
or deletions had occurred in any of the isolates in the section of the HN gene
examined. Compared with the American prototype HPIV3 strain, six mutations
occurred in the same position in all UK isolates, and of these only one resulted in
a coding change from serine to alanine (Table 2). In addition, each of the UK
isolates contained unique differences. These are summarized in Table 3 together
with the resulting coding changes where appropriate. Two mutations were seen
which occurred in five out of six of the isolates; a T C mutation at nucleotide
position 1203 and an A T mutation at nucleotide position 1518, but these did
not correlate with the year of isolation as in both instances the mutations did not
appear in a 1991 isolate, but were detected in the 1993 isolate.
A small number of mutations were observed to be isolate-specific in that certain
nucleotide positions showed mutations in only one of the variants. The MK9
strain showed the highest level, having three mutations not observed in any of the
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Table 2. Comparison of common nucleotide differences seen in tTK isolates
compared to the American prototype strain
Nucleotide
position*
969
1456
1500
1542
1627
1836
Nucleotide
change
C - T (3)t
C- T (1)
C - T (3)
A, G (3)
T - G (1)
C-T ( )
Amino acid
change
Ser - Ala [512]
Non-coding
* Nucleotide changes common to UK HPIV3 isolates compared to the American prototype
strain P13/Wash/47885/57.
t The sequence UK isolate V90/02293 is unknown at this position. The position of the
nucleotide in the triplet codon is indicated in round brackets and the amino acid residue is given
in square brackets.
Table 3. Specific nucleotide sequence differences of UK isolates compared to the
American prototype strain
Nucleotide Nucleotide*
position change
1057 G - C (1)
1203 T- C (3)
1378 (C-T (1)
1431 A - C (3)
1518 A-T (3)
1179 C - G(3)
1203 T- C (3)
1346 A - C (2)
1518 A-T (3)
1203 T-C (3)
1518 A-T (3)
1606 C-T (1)
1203 T-dC (3)
1606 C( T (1)
1134 T - C(3)
1518 A-T (3)
1825 A G ( )
1130 A-T (2)
1203 T- C (3)
1518 A -T (3)
Amino acid
change
V'al Leu [322]
His - Tyr [429]
Arg Ser [446]
Asp (lu [362]
LYs Thr [418]
Pro Ser [505]
Pro Ser [505]
Non-coding
Glu Val [346]
* Nucleotide changes specific to individual UK isolates compared to the American prototype
strain P13/Wash/47885/57. The position of the nucleotide in the triplet codon is indicated in
round brackets and the amino acid residue is given in square brackets.
other isolates, all of which were coding changes. However, this UK prototype
strain has been passaged in tissue culture more extensively than the other isolates
and this may account for some of these mutations.
The overall level of homology with the 1957 prototype strain at the nucleotide
level ranged from 988% (MK9)-99 0/% (isolates V90/02499, V91/01836 and
V93/03469). Similarly high levels of homology were found at the deduced amino
acid level, from 98-6% (MK9) to 99-3% (isolates V90/02499, V91/01836 and
V93/03469). This corresponds well with the percentage homology detected by van
Virus
isolate
MK9
V90/02293
V90/02499
V91/02200
V91/01836
V93/03469
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Wyke Coelingh, Winter and Murphy [8] in the domain 2 region of six strains
isolated over a 26-year time period, where the percentage homology between the
isolates examined and the Washington 1957 prototype strain at the amino acid
level ranged from 98 6-998 %.
From the high level of homology seen at the amino acid level and the nature of
the amino acid changes in the UK isolates it seems unlikely that any of these
mutations would alter the integral characteristics of the protein such as
hydrophobicity/charge and consequently, structure. The functionally important
regions on the HPIV3 HN protein have not been well defined although they have
been narrowed down to within the domain 2 region of the protein [8, 16], part of
which was encompassed in this study. As might be expected, no mutations were
found in any of the isolates within the fully conserved sequence NRKCS (amino
acids 252-258) proposed as the site for neuraminidase activity [17, 18].
The data from this study, together with that previously reported suggests that
the number of nucleotide differences are not directly proportional to the amount
of time between isolation of the viruses, and that progressive mutations do not
appear to accumulate. This is shown most clearly by the close relationship between
the virus strain isolated in Washington in 1957 and strains isolated nearly 40 years
later in the UK. However, it must be borne in mind that studies of this kind are
normally only able to identify forward mutations. It is possible that certain
nucleotides are particularly prone to point mutations and may oscillate around a
given forward and backward sequence. Such oscillations may not be detected by
this kind of analysis, giving an underestimation of the observed rate of mutation.
Figure 1 shows two dendrodram plots constructed from a pairwise nucleotide
comparison of the parts of the HN gene of the UK HPIV3 isolates sequenced,
together with previously reported HPIV3 HN sequence data. The comparisons
were carried out in two parts to exclude regions of sequence ambiguity, especially
in strain V90/02293. The distance on the horizontal axis is an indication of the
level of sequence divergence of the strains. A striking feature of the two
dendrograms is the apparently close relationship between the UK isolates, which
appear to be more closely related at the nucleotide level than are the tTS isolates
to each other. This may reflect the fact that all the UK isolates came from one city,
whereas the US isolates were from two geographically distant cities. It is of
interest to note that the 1957 Washington strain appears to be more closely
related to the UK isolates from the 1990s than to US isolates from the late
1970s-early 1980s. The reasons for this divergence are unclear, and a study of
HPIV3 variants isolated in the Washington area over the period 1957-79 may be
of value. The Australian isolate is also quite clearly closer in nucleotide sequence
to the UK isolates than to the US isolates. With the exception of the Texas 1982
strain, the US isolates fall into a lineage distinct from the UK/Australian isolates
and prototype strains. The Texas 1982 isolate appears more closely related to the
other US strains when comparing the 5' end of the sequenced region than the 3'
end. The 3'-end region appears to be more closely related to that of the UK strains.
This may suggest that domains exist within the HN protein, where one domain
may mutate to become more similar to the US strains and the other more similar
to the UK strains. Another possibility would be a recombination event between
two strains ofHPIV3, although currently there is no evidence to suggest that such
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(a) P13/TEX/83
P13/TEX/80
P13/WASH/79
PI3/TEX/82
P13/WASH/73
P13/AUS/74
V93/03469
V91/02200
V90/02499
MK9
V91/01836
P13/WASH/47885/57
(b) P13/TEX/80
P13/TEX/83
P13/WASH/79
P13/WASH/73
P13/TEX/82
P13/AUS/74
V91/02200
V93/03469
V91/01836
V90/02499
V90/02293
MK9
P13/WASH/47885/57
Fig. 1. Dendrogram plot of HPIV3 isolates based on the HN gene sequence. (a)
Dendrogram based on nucleotide 938 to 1347. (b) Dendrogram based on nucleotides
1363 to 1871. The dendrogram was generated by pairwise comparison of the nucleotide
sequences using the CLUSTAL program [19]. The sequence of P13/Wash/47885/57 was
taken from Elango and colleagues [15] and PL3/WASH/73, P13/AUS/74,
P13/WASH/79, P13/TEX/80, P13/TEX/82 and P13/TEX/83 were from van Wyke
Coelingh, Winter and Murphy [8].
recombination events are found within the non-segmented, single stranded,
negative sense RNA viruses.
The results illustrated in Fig. 1 show similarities to a recently reported study on
the HN protein of HPIVt [10] in which an evolutionary tree was constructed from
26 HPIV1 HN sequences spanning a 26-year time period suggesting co-circulation
of multiple lineages, but with the proviso that some of the lineages were
geographically limited. The level of variation seen in the HN gene of HPIV3 is
similar to that reported for HPIV1 which showed only a maximum of 31%
difference in the amino acid sequence of the predicted HN proteins of subgroup A
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and subgroup B isolates over a 26-year period [20]. This is similar to the situation
for influenza B and C viruses which show little sequence variation in HA genes and
no correlation in the rate of change with time [21, 22]. From these analyses it
appears that the parainfluenzaviruses and influenza B and C viruses do not
undergo the rapid evolution of new HN variants such as is seen with HA variants
of influenza A virus [23]. Similarly, populations of parainfluenzaviruses do not
show the extensive sequence variation seen with human respiratory syncytial
virus in which there may be as much as 20 % variation in the amino acid sequence
of attachment proteins of viruses of the same subgroup [24].
Comparison of the data presented here with that of van Wyke Coelingh and
colleagues [8] supports the suggestions that co-circulation of lineages occurs with
HPIV3 virus and that mutations in the HPIV3 HN gene do not correlate with the
year of virus isolation. However, this study does suggest that dominance of
geographically defined lineages may also occur in HPIV3 isolates. Analysis of a
larger number of clinical isolates should further clarify this.
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